drugset / Trial / NCT05891587
Semaglutide Therapy for Alcohol Reduction - Tulsa
Phase 2
Completed
80 enrolled
Oklahoma State University Center for Health Sciences
National Institute of Drug Abuse · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this research study is to determine if semaglutide, when compared to placebo, is safe and may reduce alcohol drinking in individuals who endorse symptoms consistent with alcohol use disorder.
Timeline
- Start
- 2023-07-07
- Primary completion
- 2025-07-30
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 1 mg | Subcutaneous |